Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.48 (
transcriptase
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Craniofacial malformations, such as
cleft palate
, present serious complications in the newborn and are often of unknown etiology. Activin BA subunit deletion leads to
cleft palate
in mice, but the expression of this protein in the human palate has not been explored. Our goal was to determine the spatial and temporal expression of inhibin/activin subunits; the binding protein, follistatin; and activin receptors in the human fetal palate. Residual human fetal palate tissues, with or without cleft, were collected during routine autopsy at Women and Infants Hospital. Inhibin/activin alpha and beta subunits, follistatin, and activin receptor protein and mRNA expression were studied by immunocytochemistry and reverse-
transcriptase
polymerase chain reaction (RT-PCR) experiments, respectively. Dimeric activin A levels were compared in cleft and normal palate tissue homogenates by immunoassay. Activin BA, follistatin, and activin receptor type IIA proteins were observed in normal and
cleft palate
tissues throughout pregnancy (gestational weeks 11 to 40). Proteins were predominantly found in developing bone cells, with no significant group differences. Inhibin/activin BA subunit, follistatin, and activin receptor mRNAs were also detected in normal and cleft fetal palate tissues, but inhibin alpha and BB subunit were absent. Inhibin/activin BA subunit expression was consistent with the presence of dimeric activin A, but levels did not differ significantly between cleft and control tissues. Inhibin/activin BA subunit, follistatin, and activin receptor proteins and mRNAs are present in the human fetal palate. These data suggest that activin signalling has the potential to be associated with human palate development.
...
PMID:Activin subunit and receptor expression in normal and cleft human fetal palate tissues. 1800 Nov 54
Cleft palate
is a common congenital abnormality that results from defective secondary palate (SP) formation. The
Sine oculis-related homeobox 2
(
Six2
) gene has been linked to abnormalities of craniofacial and kidney development. Our current study examined, for the first time, the specific role of
Six2
in embryonic mouse SP development.
Six2
mRNA and protein expression were identified in the palatal shelves from embryonic days (E)12.5 to E15.5, with peak levels during early stages of palatal shelf outgrowth. Immunohistochemical staining (IHC) showed that Six2 protein is abundant throughout the mesenchyme in the oral half of each palatal shelf, whereas there is a pronounced decline in Six2 expression by mesenchyme cells in the nasal half of the palatal shelf by stages E14.5-15.5. An opposite pattern was observed in the surface epithelium of the palatal shelf. Six2 expression was prominent at all stages in the epithelial cell layer located on the nasal side of each palatal shelf but absent from the epithelium located on the oral side of the palatal shelf.
Six2
is a putative downstream target of transcription factor
Hoxa2
and we previously demonstrated that
Hoxa2
plays an intrinsic role in embryonic palate formation. We therefore investigated whether
Six2
expression was altered in the developing SP of
Hoxa2
null mice. Reverse
transcriptase
PCR and Western blot analyses revealed that
Six2
mRNA and protein levels were upregulated in
Hoxa2
-/-
palatal shelves at stages E12.5-14.5. Moreover, the domain of Six2 protein expression in the palatal mesenchyme of
Hoxa2
-/-
embryos was expanded to include the entire nasal half of the palatal shelf in addition to the oral half. The palatal shelves of
Hoxa2
-/-
embryos displayed a higher density of proliferating, Ki-67 positive palatal mesenchyme cells, as well as a higher density of Six2/Ki-67 double-positive cells. Furthermore,
Hoxa2
-/-
palatal mesenchyme cells in culture displayed both increased proliferation and elevated
Cyclin D1
expression relative to wild-type cultures. Conversely, siRNA-mediated
Six2
knockdown restored proliferation and
Cyclin D1
expression in
Hoxa2
-/-
palatal mesenchyme cultures to near wild-type levels. Our findings demonstrate that
Six2
functions downstream of
Hoxa2
as a positive regulator of mesenchymal cell proliferation during SP development.
...
PMID:
Six2
Plays an Intrinsic Role in Regulating Proliferation of Mesenchymal Cells in the Developing Palate. 2921 17